IL17A and diabetes mellitus: Additionally, IL-17A synergistically interacts with other inflammatory cytokines, and the overall dysregulation of these mediators may participate in host alterations that lead to oral dysbiosis and play a pivotal role in the pathogenesis of DM, atherosclerosis, RA, and adverse pregnancy outcomes.